I

ImmunoLogik GmbH

2 employees

The ImmunoLogik develops a novel class of substances for the fight against viral infections.

Basic info

Industry

biotechnology research

Sectors

COVID-19
Biotechnology
SARS-CoV-2
HIV
Pharmazie
AIDS
Wirkstoffentwicklung
Drug development

Date founded

2012

Funding rounds raised

Total raised

$356K

from 1 investors over 1 rounds

I

ImmunoLogik GmbH raised $356K on August 1, 2017

Investors: aescuvest

FAQ